RGC
Regencell Bioscience Holdings Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$6.71
−2.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 249.25x
- Price / sales
- —
- Price / cash flow
- -432.38x
Enterprise value
- Enterprise value
- $3.3B
- EV / sales
- —
- EV / EBITDA
- -292.71x
- EV / EBIT
- -282.61x
- Market cap
- $3.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026